Cost-effectiveness of recombinant human erythropoietin for preventing transfusions in critically ill patients

被引：1
|
作者：
Sullivan, PW [1 ]
MacLaren, R [1 ]
机构：
[1] Univ Colorado, Sch Pharm, Denver, CO 80202 USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64194-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：338 / 338
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients
    MacLaren, R
    Sullivan, PW
    [J]. VALUE IN HEALTH, 2005, 8 (02) : 105 - 116
  • [2] Cost-effectiveness of rHuEPO for reducing RBC transfusions in critically ill patients.
    MacLaren, R
    Sullivan, PW
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1428 - 1428
  • [3] Recombinant human erythropoietin therapy in critically ill patients
    D Georgopoulos
    D Matamis
    N Xirouchaki
    C Routsi
    A Michalopoulos
    A Maggina
    G Dimopoulos
    E Zakynthinos
    G Nakos
    G Thomopoulos
    K Mandragos
    G Vasiliadou
    M Peftoulidou
    A Maniati
    [J]. Critical Care, 9 (Suppl 1):
  • [4] Erythropoietin and transfusions among critically ill patients
    Abbott, KC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (12): : 1511 - 1512
  • [5] Comparison of lower doses of recombinant human erythropoietin (rHuEPO) in reducing transfusions in the critically ill
    Rotello, LC
    Albrant, D
    Chan, TW
    Fontana, J
    Means-Markwell, M
    Golden, T
    Gumlia, A
    Rainey, T
    [J]. CHEST, 2003, 124 (04) : 126S - 127S
  • [6] Erythropoietin and transfusions among critically ill patients - Reply
    Corwin, HL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (12): : 1512 - 1512
  • [7] EFFICACY OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CRITICALLY ILL ANAEMIC SEPTIC PATIENTS
    Effat, H. S.
    [J]. INTENSIVE CARE MEDICINE, 2010, 36 : S406 - S406
  • [8] Response to the randomized trial of recombinant human erythropoietin in critically ill patients
    Belova, Eva
    Kanna, Balavenkatesh
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (06) : 1632 - 1632
  • [9] Outcomes with the Use of Recombinant Human Erythropoietin in Critically Ill Burn Patients
    Lundy, Jonathan B.
    Hetz, Katherine
    Chung, Kevin K.
    Renz, Evan M.
    White, Christopher E.
    King, Booker T.
    Huzar, Todd
    Wolf, Steven E.
    Blackbourne, Lorne H.
    [J]. AMERICAN SURGEON, 2010, 76 (09) : 951 - 956
  • [10] Best evidence in critical care medicine - The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients
    不详
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2004, 51 (06): : 621 - 621
12345